Pharmaceutical

CNS market resurgence: a decade-long slump ends with $80bn milestone

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround.

Apr 2, 2025 - 06:00
CNS market resurgence: a decade-long slump ends with $80bn milestone
In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround.
Read the original article

Tags:

Previous Article

Magazine: Are European biopharma manufacturers ‘nearshoring’?

Next Article

Judge rejects J&J’s $9bn talc settlement for third time

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Light Horse emerges with $62m and Novartis partnership worth up to $1bn

Light Horse emerges with $62m and Novartis partnership ...

Jan 12, 2025

Opinion: I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

Opinion: I’m an anesthesiologist. Kenneth Smith’s execu...

Jan 30, 2024

Allscripts Healthcare Solutions gets grant for optimizing patient overview in user interface for medical processing device

Allscripts Healthcare Solutions gets grant for optimizi...

Jun 8, 2024